July 23 (Reuters) - Mesoblast Ltd (MSB) :
- FDA ACCEPTS MESOBLAST’S BIOLOGICS LICENSE APPLICATION (BLA) FOR RYONCIL® IN CHILDREN WITH STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE (SR-AGVHD)
- MESOBLAST LTD - MESOBLAST ANTICIPATES A DECISION ON OR BEFORE FDA'S PRESCRIPTION DRUG USER FEE ACT (PDUFA) GOAL DATE OF JANUARY 7, 2025.
- Forums
- ASX - By Stock
- MSB
- News: MSB FDA Accepts Mesoblast’S Biologics License Application For Ryoncil®
News: MSB FDA Accepts Mesoblast’S Biologics License Application For Ryoncil®
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.35 |
Change
0.105(8.43%) |
Mkt cap ! $1.541B |
Open | High | Low | Value | Volume |
$1.27 | $1.40 | $1.27 | $16.46M | 12.22M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 59739 | $1.35 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.36 | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 59739 | 1.350 |
4 | 14088 | 1.345 |
2 | 47555 | 1.340 |
3 | 94633 | 1.335 |
4 | 66925 | 1.330 |
Price($) | Vol. | No. |
---|---|---|
1.360 | 5000 | 1 |
1.365 | 56441 | 4 |
1.370 | 140305 | 9 |
1.375 | 37954 | 3 |
1.380 | 113521 | 16 |
Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |